Lanreotide 120 MG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FFGS0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,916
Award facts
- Contract value 100% obligated
- $24,916.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,916.14 delivery order to AmerisourceBergen Drug Corp for Lanreotide 120 mg/0.5 ml syringes on September 3, 2025, with completion scheduled for September 4, 2025. Lanreotide is a somatostatin analog used to treat acromegaly and neuroendocrine tumors, representing specialized pharmaceutical inventory required by military and federal healthcare systems. This non-set-aside award was competitively procured under firm fixed pricing terms, with performance to be executed at the contractor's Conshohocken, Pennsylvania location.
This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement with demonstrated capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DB25FFGS0?
SPE2DB25FFGS0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FFGS0 worth?
The government has obligated $24,916 on SPE2DB25FFGS0.
Is contract SPE2DB25FFGS0 an order under another contract?
Yes. SPE2DB25FFGS0 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFGS0 competed?
The extent of competition for SPE2DB25FFGS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award